Breast Cancer Canada and AstraZeneca Canada Advance Next-Generation Survivorship Research
Announced at ESMO 2026: $200,000 in matched funding to advance the future of Canadian breast cancer survivorship. TORONTO — Breast Cancer Canada and AstraZeneca Canada are investing $200,000 in matched research funding to address critical gaps in breast cancer survivorship and improve care for Canadians living with and beyond the disease. Announced at Breast Cancer […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
